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Abstract:  A classification of intraoperative cardio-vascular complications (CVC) was 
performed, based on data from 466 patients subjected to emergency surgery, due to severe 
abdominal surgical diseases or traumas, in accordance with the severe criteria of ACC/AHA 
for CVC in noncardiac surgery. There were 370 intraoperative CVC registered, distributed 
as follows: groups with low risk (148), moderate risk (200), and high risk (22). Patient 
groups were formed, according to the CVC risk level, during the intraoperative period, for 
which the determinant factor for the group distribution of patients was the complication with 
the highest risk. Individual data was collected for each patient, based on 65 indices: age, 
physical status, diseases, surgical interventions, anaesthesiological information, intra and 
postoperative cardio-vascular complications, disease outcome, causes of death, cardio-
vascular disease anamnesis, anamnesis of all other nonsurgical diseases present, laboratory 
results, results from all imaging and instrumental examinations, etc. On the basis of these 
indices, a new distribution of the risk factors was implemented, into groups with different 
levels of risk of CVC during intraoperative period. This result is a solid argument, 
substantiating the proposal to introduce these adjustments for determining the severity of 
CVC in the specific conditions of emergency abdominal surgery. 
 
Keywords: Cardiac risk, Methods of perioperative risk assessment, Emergency abdominal 
surgery. 
 
Introduction 
Emergency abdominal surgery is an area in which the possibilities for a number of cardiologic 
tests and methods for perioperative cardiac risk evaluation are limited [7, 8, 9, 15]. Our 
former studies [10, 11, 12, 14] show the low reliability of the known indices for cardiac risk 
evaluation: of Goldman [2, 3, 4], of Larsen [6] and of Detsky [1] in patients subject to 
emergency abdominal operations with and without perioperative cardiovascular accidents. 
 
The evaluation of cardiac risk as part of the total operative risk defines the probability for 
onset of cardiac complications during the operation and in the postoperative period, enables 
prediction of complication severity (based on the standards adopted by ACC/AHA [5]) and 
the period of their onset. Thus such evaluation is a prerequisite for recommendations about 
the therapeutic and surgical tactics. 
 
The aim of this study is to outline constellations of risk factors for the emergence of 
perioperative cardiac complications in patients subject to emergency abdominal surgery and  Bioautomation,  2008,  9, 40-49  ISSN 1312 – 451X  
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thus to generate screening models for prediction of intraoperative cardiovascular 
complications with specific risk level. 
 
Method and materials 
Data have been used about 508 patients subjected to emergency operation in Emergency 
Surgery Section of N. Pirogov University Hospital for Emergency Care. All patients suffer 
from acute surgical abdominal diseases and are distributed in nosologic groups of different 
severity – Table 1. Since a small number of patients falls into groups from F to I, which limits 
the application of statistical methods, the study is concentrated on groups from A to E 
(hereinafter referred to as Studied Nosologic Groups – SNG), encompassing 466 (91.7%) of 
the patient contingent.  
 
       Table 1. Nosologic groups of urgent abdominal surgical diseases 
Group Code  Number 
Acute appendicitis   A 102 
Complicated hernia  B 92 
Stomach-duodenal   C 84 
Liver-billiary-pancreatic  D 108 
Intestinal  E 80 
Abdominal traumas  F 10 
Combined traumas involving the abdomen  G 13 
Gynecological  H 6 
Others (not subject to classification)  I 13 
 
The recorded intraoperative cardiovascular complications (CVC) for the SNG are 370 and are 
classified according to the ACC/AHA criteria – Table 2. 
 
Among the 508 patients there are 97 for whom preoperative data are available for cardiac 
pathology, but intra- or postoperative CVC did not occur. This patient group represents the 
control group (CG) in comparison to which the differences in the SNG patient data were 
studied. 
Patient contingent data were collected from the personal anamneses, physical examination, 
patient history, special hospital documentation and are structured in 4 subgroups: 
1.  Personal data; surgical diseases (SD); operative interventions; data related to the 
anesthesia; intraoperaive surgical and cardiovascular complications; about the 
medication of the intraoperaive CVC; outcome of the diseases and death cause; 
2.  CVD anamnesis; from anamneses for other non-surgical accompanying diseases; 
physical status; 
3. Laboratory  investigations; 
4.  Image and instrumental investigations. 
 
Each indicator in the data groups has got own internal structure of category parameters, which 
are coded with respective quantitative value for the purpose of storage and statistical 
processing – Table 3. The management of the collected data is carried out with CardioRisk 
subject-oriented database [13] developed by the authors on the basis of Microsoft Access®. 
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Table 2. Intraoperative cardiovascular complications 
Risk type  Complication type 
Number of 
complications 
Number 
of patients
Low 
Transient hypotension 
Transient transitory hypertension 
Supraventricular extrasystoles 
Ventricular extrasystoles 
70 
63 
13 
2 
69 
 Total:  148   
Moderate 
Non-provoked prolonged hypertension (> 1 hour)
Prolonged hypertension (> 1 hour) 
Supraventricular arrhythmia (atrial fibrillation, 
supraventricular tachycardia) 
Raised heart rate (> 120 beats per minute) 
Sinus bradycardia 
Manifested ischemia (on ECG) 
Frequent ventricular extrasystoles 
22 
24 
11 
55 
7 
44 
37 
198 
 Total:  200   
High 
Hypertension in the case of sudden heart failure 
Ventricular extrasystoles class 4 
Ventricular tachycardia 
Acute myocardial infarction 
Acute cardiogenic pulmonary edema 
Cardiac arest 
6 
5 
5 
4 
1 
1 
22 
 Total:  22   
 
Variation analysis is applied and Student's t-criteria for assessment of the possibility for 
differentiation between average values or frequencies (relative shares). 
 
Results 
Table 4 shows the values of the calculated t-criteria for differentiation between the indicators 
by couples of groups according to degree of severity of the intraoperative CVC: high risk 
CVC in relation to the CG and in relation to moderate risk CVC group; moderate risk CVC in 
relation to the CG and in relation to low risk CVC; low risk CVC in relation to the CG. There 
is not a single case of intraoperative cardiogenic death. The calculated t-values exceeding the 
limit values at p < 0.05 (for respective degrees of freedom) are marked with *. 
 
The data presented in Table 4 enable differentiation of specific constellations of indicators 
(risk profiles) which are sensitive to the appearance of intraoperative CVC with different 
degree of the cardiac risk. 
 
I. Constellation of indicators sensitive to the appearance of low risk intraoperative CVC 
1. Age (62 and 49); 2. AH (52.2% and 20.7%); 3. RD (26.1% and 5.2%); 4. HF (50.7% and 
22.7%); 5. SAP (raised for 59.4% and 40.2%, and reduced for 11.6% and 9.3%);   
6. DAP (raised for 49.3% and 32%, and reduced for 23.2% and 26.8%). 
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Table 3. Coding of indicators (the extension Op stands for intraoperative values) 
Indicator Description  Coding 
Age  Age  1 – >[18-40]; 2 – >[41-55]; 3 – >[56-65]; 
4 – >[66-75]; 5 – >[76-90]; 6 – >> 90 
COpT  Condition of 
operative treatment  0 – urgent (emergency or early postponed); other – 1 
EOpInt  Extent of the 
operative intervention  1 – small; 2 – medium; 3 – large 
DAnest  Duration of 
the anesthesia 
1 – up to 60 min, 2 – from 61 to 120 min, 
3 – from 121 to 180 min, 4 – over 180 min 
TIP  Total intubation 
period 
0 – no, 1 – up to 1 h, 2 – from 1 to 2 h, 
3 – from 2 to 3 h, 4 – from 3 to 6 h, 
5 – from 6 to 12 h, 6 – over 12 h, 7 – over 24 h 
SuOpE 
Surgical complications 
established or ensued 
during the operation 
0 – no; 1 – local pyoperitoneum or local 
choleperitoneum; 3 – intraoperative 
haemorrhage, traumatic or hypovolemic shock, 
septic or endotoxic shock; 2 – all other cases 
CVC-LR-
Op 
Non-surgical 
interoperative 
complications, low risk 
0 – if no; otherwise 1 
CVC-MR-
Op 
Non-surgical 
interoperative 
complications, 
medium risk 
0 – if no; otherwise 1 
CVC-HR-
Op 
Non-surgical 
interoperative 
complications, high risk
0 – if no; otherwise 1 
SPOpC  Surgical postoperative 
complications 
0 – no; 2 – dehiscention of the operative wound 
necessitating laparotomy; 3 – postoperative 
haemorrhage or postoperative peritonitis 
necessitating laparotomy, ileus or other 
spontaneous postoperative complication 
necessitating relaparotomy; 1 – all other cases 
CVC-LR 
Non-surgical 
postoperative 
complications (low) 
0 – if no; otherwise 1 
CVC-MR 
Non-surgical 
postoperative 
complications (medium)
0 – if no; otherwise 1 
CVC-HR 
Non-surgical 
postoperative 
complications (high) 
0 – if no; otherwise 1 
nonCD  Cause of death, 
non-cardiogenic 
0 – if no death occurred; 1 – if death occurred; 
2 – if there is more than one reason for the death 
CD  Cause of death, 
cardiogenic 
0 – if no death occurred; 1 – if death occurred; 
2 – if there is more than one reason for the death 
AH  Arterial hypertension, 
degree 
0 – no; 1 – labile; 2 – mild; 3 – moderate; 
4 – severe; 5 – ISAH  Bioautomation,  2008,  9, 40-49  ISSN 1312 – 451X  
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Table 3. Continuation 
 
IHD  Ischemic heart 
disease 
0 – no; 1 – stable fk 1-2; 2 – stable fk2-3; 
3 – stable fk3-4; 4 – non-stable during the last 
3 months; 5 – non-stable during the last 6 months 
MI  Myocardial 
infarction  0 – no; 1 – yes 
RD  Rhythm 
disorders 
0 – no; 1 – supraventricular; 2 – ventricular; 
3 – atrial fibrillation; 4 – STC 
HF  Heart failure  0 – no; 1 – fk1; 2 – fk2; 3 – fk3; 4 – fk4; 
5 – for the others 
CNPD  Chronic nonspecific 
pulmonary diseases 
0 – no; 1 – without cor pulmonale; 
2 – with cor pulmonale 
DM 
(Diabetes)   Diabetes  0 – no; 1 – type 1, 2 – type 2 
L-Res  0 – norm; 1 – dyspnea; 2 – orthopnea; 
3 – tachypnea; 4 – IBV 
L-ResOp 
Lung respiration 
 
L-Aus  0 – no find; 1 – moist rales; 2 – dry rales; 
3 – (1+2); 4 – lung edema 
L-AusOp 
Lung auscultatory 
 
SAP 
0 – if the value is > 100 and < 140; 1 – if the 
value is ≤ 100; 2 – if the value is ≥ 140 
SAP-Op 
Blood pressure, 
in mm H2O-syst. 
 
DAP 
0 – if the value is > 70 and < 90; 1 – if the 
value is ≤ 70; 2 – if the value is ≥ 90 
DAP-Op 
Blood pressure, 
in mm H2O-diast. 
 
CVP  0 – if the value is less than 90; 1 – in all others cases 
CVP-Op 
Central venous 
pressure: in mm H2O   
HR  0 – if the value is less than 100; 1 – in all others cases
HR-Op 
Rate: beats per 
minute   
CR  0 – no; 1 – sinus rhythm; 2 – abs. arrhythmia; 
3 – pace-maker 
CR-Op 
Heart, rhythm 
 
HAusc  0 – no; 1 – systolic murmur; 2 – diastolic murmur;  
3 – TZ-cantering; 4 – (1+3) 
HAusc-Op 
Heart, auscultatory 
 
Hb  1 – if Hb < 100; 0 – in other cases 
Hb-Op 
Hemoglobin 
 
Glu  1 – if Glu < 3 or Glu > 6; 0 – in all other cases 
Glu-Op 
Glucose 
 
Urea  1 – if Urea > 8.2; 0 – in all other cases 
Urea-Op 
Urea 
 
Crea  1 – if Crea > 134; 0 – in all other cases 
Crea-Op 
Creatinine 
 
Potassium  1 – if P < 3 or P > 6; 0 – in all other cases 
Potassium-
Op 
Potassium 
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Table 3. Continuation 
SGOT  1 – if SGOT > 12; 0 – in all other cases 
SGOT-Op 
Enzymes – sgot 
 
SGPTT  1 – if SGPT > 12; 0 – in all other cases 
SGPT-Op 
Enzymes - sgpt 
 
Rö L  1 – left ventricle hypertrophy; 2 – congestion, 
effusion; 3 – OBO; 0 – in all other cases 
Rö L-Op 
Rö Lung 
 
LVH  1 – left ventricle hypertrophy; 0 – in all other cases 
LVH-Op 
ECG overburden 
 
Isch-ECG  Myocardial 
ischemia – preoperative
1 – if in the Isch-ECG or in the Isch-ECG-Op 
there is a value, different from 0; in all  
other cases – 0 
Isch-ECG-
Op 
Myocardial 
ischemia –  
intraoperative 
1 – if in the Isch-ECG-Op there is a value, 
different from 0; in all other cases – 0 
 
  Table 4. T-criteria for differentiation between the indicators 
Indicator LR-RG  MR-RG HR-RG MR-LR  HR-MR 
Age  *5.9811 *4.9347 1.4123  1.7756 *3.2400 
AH  *3.8142 *2.5123  *2.4817 *2.0653 1.4490 
IHD  0.9172 *3.0918  *1.9791 1.3684 1.1453 
MI  1.2362 1.5654  *2.4479 1.3351  *2.0429 
RD  *3.3619 *2.5259  *2.0561 *1.9861 1.3034 
HF  *4.2184 *5.4973  *4.7256 0.4626 *2.9815 
CNPD  1.4316 *4.8549  *2.6268 0.9042 0.9124 
DM   0.4480 0.3663  0.6412  0.8526 0.4901 
L-Res  1.5618 *4.6786  *3.0663 *2.3763 1.4131 
L-Aus  1.6500 *3.7460  *3.0432 1.1646 *2.0192 
SAP  *4.0255 *3.1690 0.9257 *1.9853 0.1811 
DAP  *11.6654 *16.9698 1.8498 1.3099 0.7776 
CVP  N.A. N.A.  N.A.  N.A.  1.8940 
HR  0.4810 *4.9068  *2.1303 *3.7383 0.3586 
CR  1.5068 1.4462  1.2319  1.1265 1.5020 
HAusc  0.3664 1.7670  *2.2361 *2.0306  *1.9723 
Hb  0.7192 *2.8112  *2.4479 *3.6225  *2.0165 
Glu  N.A. 1.8103  *3.6018 *8.4877  *2.0007 
Urea  0.0073 0.4137  0.9915  0.3597 1.8835 
Crea  N.A. N.A.  1.8062  0.4916  1.8306 
Potassium  0.8189 0.3589  0.7541  0.6252 0.6548 
SGOT  0.8098 1.2104  1.3703  0.0797 0.9865 
SGPT  0.8345 0.5498  1.2261  0.4773 1.0543 
Rö L  1.2774 *2.9410  *2.4092 0.1622 1.4804 
LVH  1.0411 0.6978  1.1359  *1.6710  0.8494 
Isch-ECG  1.0000 *11.3159 *4.1833 *10.0625 0.5312 
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II. Constellation of indicators sensitive to the appearance of moderate risk intraoperative 
CVC 
II.1. Comparison between the indicators for the patients from the group with 
moderate risk complications and the control group of patients: 1. age (60 and 49); 2. AH 
(37.4% and 22.7%); 3. IHD (3.5% and 4.1%); 4. RD (17.1% and 5.2%); 5. HF (46.5% and 
22.7%); 6. CNPD (24.3% and 7.2%); 7. lung respiration (17.2% and 2.1%); 8. lung 
auscultatory find (18.7% and 4.1%); 9. SAP (raised for 48% and 40.2%, and reduced for 
12.6% and 9.3%); 10. DAP (raised for 39.9% and 32%, and reduced for 26.3% and 26.8%); 
11.  raised HR (63% and 34%); 12. reduced hemoglobin values (11% and 3%); 
13. pathology Rö-lung (13.6% and 5.2%); 13. manifested ischemia on ECG (39% and 0%). 
 
II.2. Comparison between the indicators for the patients from the groups with 
moderate risk intraoperative CVC and with low risk CVC: 1. AH (37.4% and 52.2%); 
2. RD (17.1% and 26.1%); 3. pathology lung respiration (17.2% and 7.3%); 4. SAP (raised 
for 48% and 59.4%, and reduced for 12.6% and 11.6%); 5. raised HR (63% and 38%); 
6. heart auscultatory find (10.6% and 5.8%); 7. reduced hemoglobin values (11% and 
1%); 8. increased serum glucose (63% and 5%); 9. LVH on ECG (19% and 29%); 
10. manifested ischemia on ECG (39% and 1%).  
 
III. Constellation of indicators sensitive to the appearance of high risk intraoperative CVC 
III.1. Comparison between the indicators for the patients from the group with 
high risk complications and the control group: 1. AH (50% and 22.7%); 2. IHD (13.6% 
and 4.1% with considerable internal differences); 3. myocardial infarction (27.3% and 
3.1%); 4. RD (27.2% and 5.2%); 5. HF (72.7% and 22.7%); 6. CNPD (36.4% and 7.2%); 
7. pathology lung respiration (36.4% and 2.1%); 8. lung auscultatory (45.5% and 4.1%); 
9. raised HR (59% and 34%); 10. heart auscultatory find (27.3% only of the first group 
with high relative frequency of T3 gallop); 11. reduced hemoglobin values (27% and 3%); 
12. increased serum glucose (82% and 46%); 13. pathology Rö - lung (31.8% and 6.2%); 
14. manifested ischemia on ECG (45.5% and 0%). 
 
III.2. Comparison between the indicators for the patients from the group with 
high risk intraoperative CVC and the group with moderate risk intraoperative CVC: 
1. age (66 and 60); 2. MI (27.3% and 7%); 3. HF (72.7% and 46.5%); 4. lung auscultatory 
(45.5% and 17.2%); 5. heart  auscultatory (27.3% and 10.6%); 6. reduced hemoglobin 
values (27% and 11%); 7. increased serum glucose (82% and 64%). 
 
The comparative quantitative data, summarized in chapters PI, PII and PIII, combined with 
the severity of the SD (Table 5) enable identification of specific profiles (screening models) 
of the basic patient groups by CVC type. 
 
Patient group (69 cases) with low risk intraoperative CVC 
The average age in this group is 62. Typical characteristics are AH, rhythm disorders, 
HF (50.7%), SAP and DAP. SD are most often of group B (24%), the rest are almost equally 
distributed among A, C, D and E. 
 
Patient group (198 cases) with moderate risk intraoperative CVC 
Average age – 60. Specific prognostic indicators are: IHD, CNPD, lung-respiration, lung-
auscultatory, raised heart rate, heart-auscultatory, reduced hemoglobin values, raised serum 
glucose, Rö-lung, manifested ischemia on preoperative ECG. The most frequent SD for this  Bioautomation,  2008,  9, 40-49  ISSN 1312 – 451X  
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group are those from the relatively more-severe category D, and relatively rare – from the 
mildest one (A). 
 
Table 5. Distribution of surgical diseases by groups of  
intraoperative cardiovascular complications 
Group CG  CG%  Low
risk  LR%  Moderate
risk  MR%  High 
risk  HR% 
A 22 22.7  10  14.5 15  7.6    
B 18 18.5  17  24.6 38  19.2  5  22.7 
C 28 28.9  10  14.5 38  19.2  2 9.1 
D  14  14.5  11  15.9 48  24.2  9  40.9 
E  11 11.3  10  14.5 33  16.7  6  27.3 
F  1 1.0  1  1.4  5 2.5     
G  2 2.1  3  4.3  8 4.0     
H  1 1.0  4  5.8  4 2.0     
I     3  4.3 9  4.5     
Total for groups:  A,B,C,D    A,B,C,D,E   B,C,D,E   B,C,D,E 
%   84.6    84.0   79.3    100.0 
 
Patient group (22 cases) with high risk intraoperative CVC 
Significant indicators for this group, although with non-typical differences from the previous 
one are average age – 66, AH, RD, reduced hemoglobin, raised serum glucose (82%). More 
sensitive indicators are: CNPD, raised HR, ischemia on preoperative ECG, IHD, HF, lung-
respiration, lung-auscultatory, heart-auscultatory, Rö-lung. Particularly important indicator in 
this case is MI. The severity of the surgical diseases visibly increases to groups D and E. 
 
Summary of results and conclusions 
The systematized profiles binding the patient groups by risk degree with constellations of 
indicators the preoperative values of which are group-specific, allow for formulating 
guidelines for advance prognosis for occurrence of intraoperative CVC with specific risk level 
and surgical disease diagnosis: 
•  Age, AH, RD or HF anamneses could be defined as prognostic factor for all groups 
of intraoperative CVC; 
•  IHD, HR, pathologic auscultatory heart find, manifest ECG ischemia, indicators 
for lung pathology (CNPD, pathologic modifications of breathing mechanic and 
the lung auscultation, Rö-lung pathology), increased serum glucose and reduced 
hemoglobin values have prognostic significance for moderate risk and high risk 
intraoperative CVC; 
•  The previous MI is a serious predictor of high risk CVC. 
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